Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
This page is not indexed by search engines while we improve data quality.
EWHA University—Industry Collaboration Foundation — Human Necessities
EWHA University—Industry Collaboration Foundation holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | EWHA University—Industry Collaboration Foundation |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking EWHA University—Industry Collaboration Foundation to Human Necessities.
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Recent filings
Latest patents from EWHA University—Industry Collaboration Foundation in Human Necessities.
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof
US-9259412-B2 · Feb 16, 2016 · US
Related pages
Navigate to parent entity pages.